Diagomics strengthens its position in the cancer diagnosis market by joining the European ZytoMax group.

To reinforce our position on the market and to continue offering high performance and innovative products, Diagomics joined ZytoMax group on the 23rd of January 2023. The cornerstones of this new area are our common values about both scientific expertise and proximity with customers. Thanks to this merging, Diagomics evolves and expands its activity by your side.

Official statement